US patients given first dose of coronavirus antibody treatment

Researchers say LY-CoV555 is the first potential new medicine specifically designed to attack the virus that causes Covid-19.

Patients have been given the first dose of a potential antibody treatment designed to fight coronavirus.

Scientists developed the antibody in just three months after identifying it from blood taken from one of the first American patients to recover from Covid-19.